<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01615640</url>
  </required_header>
  <id_info>
    <org_study_id>02.08.2010 V.1.0</org_study_id>
    <nct_id>NCT01615640</nct_id>
  </id_info>
  <brief_title>Diffusion Study on Patients With Osteosarcoma</brief_title>
  <official_title>Monitoring the Response of Osteosarcoma Under Neoadjuvant Chemotherapy: The Value of Dynamic Contrast Enhancement and Diffusion-weighted MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Stuttgart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Stuttgart</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the accuracy of dynamic contrast enhanced and
      diffusion-weighted MR Imaging in evaluating response to chemotherapy in osteosarcoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging have the
      potential to measure early cellular and vascular changes that occur in response to
      chemotherapy and could therefore be early predictors of therapeutic response.

      Aim of our study is to assess the accuracy of dynamic contrast enhanced and
      diffusion-weighted MR imaging in evaluating response to chemotherapy during the preoperative
      treatment of osteosarcoma. Patients will undergo dynamic contrast-enhanced and
      diffusion-weighted magnetic resonance imaging before, during and after chemotherapy.

      Our long-term goal is to use these imaging techniques to develop non-invasive methodologies
      that would be better predictors of tumor response than the current clinical standard and
      earlier predictors than histological evaluation of the whole tumor.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Osteosarcoma</condition>
  <arm_group>
    <arm_group_label>Osteosarcoma patients</arm_group_label>
    <description>Patients with an histologically proven osteosarcoma will be entered into the study.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        German, Austrian and Swiss patients with an osteosarcoma will be entered into the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed diagnosis of osteosarcoma of all entities

          -  Written informed consent of patient

        Exclusion Criteria:

          -  No written informed consent

          -  Contraindications to MRI (pacemaker, aneurysm clip, mechanical and/or electrical
             device or metallic fragment, severe claustrophobia)

          -  Severe, active co-morbidity

          -  Major medical illnesses or psychiatric impairments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thekla von Kalle, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Stuttgart</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thekla von Kalle, Doctor</last_name>
    <phone>+49 (0) 711/ 278-73303</phone>
    <email>t.vonkalle@klinikum-stuttgart.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinikum Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>70176</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2012</study_first_submitted>
  <study_first_submitted_qc>June 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2012</study_first_posted>
  <last_update_submitted>June 7, 2012</last_update_submitted>
  <last_update_submitted_qc>June 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Stuttgart</investigator_affiliation>
    <investigator_full_name>Dr. Thekla von Kalle</investigator_full_name>
    <investigator_title>Dr. Thekla von Kalle</investigator_title>
  </responsible_party>
  <keyword>Osteosarcoma</keyword>
  <keyword>Response of chemotherapy</keyword>
  <keyword>Dynamic contrast medium examination</keyword>
  <keyword>Diffusion-weighted MR imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteosarcoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

